Related Experiment Videos
Cancer control in women. Update 2003
P Boyle1, M E Leon, P Maisonneuve
1Dept. of Epidemiology and Biostatistics, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. director.epi@ieo.it
Summary
Cancer incidence in women is rising, particularly lung cancer due to smoking. Prevention and screening are key cancer control strategies for women's health.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Global cancer burden in women is increasing, with notable rises in breast, cervix, lung, and colorectal cancers.
- Lung cancer rates in women are rising significantly, potentially surpassing breast cancer as a leading cause of cancer death globally.
- Cigarette smoking, widely adopted by women in the latter half of the 20th century, is a primary driver of these trends.
Purpose of the Study:
- To review current knowledge on the epidemiology of cancer in women.
- To identify key cancer control strategies, emphasizing prevention and screening.
- To highlight emerging roles for HPV testing in cervical cancer screening.
Main Methods:
- Literature review of epidemiological data on cancer in women.
- Analysis of trends in cancer incidence and mortality.
- Evaluation of the impact of lifestyle factors (smoking) and medical interventions (hormonal therapies, screening).
Main Results:
- Smoking cessation and prevention are paramount cancer control strategies for women.
- Screening effectively reduces incidence and mortality for cervical cancer and mortality for breast and colorectal cancers.
- Oral contraceptive use shows mixed effects: slight increase in breast cancer risk, but protective against ovarian and endometrial cancers. Hormonal Replacement Therapy (HRT) increases endometrial and possibly breast cancer risk.
Conclusions:
- Preventing cigarette smoking and encouraging cessation are the most critical cancer control measures for women.
- Screening programs for cervical, breast, and colorectal cancers are vital.
- HPV testing shows promise for enhancing cervical cancer screening effectiveness.